Approaches to gene therapy for human immunodeficiency virus infection

被引:39
作者
Buchschacher, GL
Wong-Staal, F
机构
[1] Univ Calif San Diego, Div Hematol Oncol, La Jolla, CA 92093 USA
[2] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA
[3] Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA
关键词
D O I
10.1089/104303401750214249
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Much progress has been made in developing new and more efficient treatments for human immunodeficiency virus (HIV) infection, the cause of acquired immunodeficiency syndrome (AIDS). However, the scope of the HIV epidemic and the limitations of existing treatments necessitate the continued development of novel treatment strategies. Gene therapy is one such forward-looking strategy. Gene therapy approaches for HIV infection include efforts to interfere with viral replication directly by engineering HIV-resistant cells or indirectly by eliminating infected cells from the body, primarily by eliciting a therapeutic immune response to destroy HIV-infected cells. Although the prospect of gene therapy as a routine treatment for HIV infection remains distant, continuous progress is being made, which should also have implications for gene therapy strategies for a variety of other diseases. This article reviews some of the strategies for investigating the feasibility of gene transfer for the treatment of HIV infection.
引用
收藏
页码:1013 / 1019
页数:7
相关论文
共 64 条
  • [1] Biomedicine - Lentiviral vectors - the promise of gene therapy within reach?
    Amado, RG
    Chen, ISY
    [J]. SCIENCE, 1999, 285 (5428) : 674 - 676
  • [2] Characterization of anti-CCR5 ribozyme-transduced CD34+ hematopoietic progenitor cells in vitro and in a SCID-hu mouse model in vivo
    Bai, JR
    Gorantla, S
    Banda, N
    Cagnon, L
    Rossi, J
    Akkina, R
    [J]. MOLECULAR THERAPY, 2000, 1 (03) : 244 - 254
  • [3] Dendritic cells and the control of immunity
    Banchereau, J
    Steinman, RM
    [J]. NATURE, 1998, 392 (6673) : 245 - 252
  • [4] Diphtheria toxin A gene-mediated HIV-1 protection of cord blood-derived T cells in the SCID-hu mouse model
    Banda, NK
    Akkina, RK
    Terrell, K
    Shpall, EJ
    Tomczak, J
    Campain, J
    Claman, H
    Cagle, L
    Harrison, GS
    [J]. JOURNAL OF HEMATOTHERAPY, 1998, 7 (04): : 319 - 331
  • [5] Inhibition of human immunodeficiency virus-1 (HIV-1) replication after transduction of granulocyte colony-stimulating factor-mobilized CD34(+) cells from HIV-1-infected donors using retroviral vectors containing anti-HIV-1 genes
    Bauer, G
    Valdez, P
    Kearns, K
    Bahner, I
    Wen, SF
    Zaia, JA
    Kohn, DB
    [J]. BLOOD, 1997, 89 (07) : 2259 - 2267
  • [6] RevM10-expressing T cells derived in vivo from transduced human hematopoietic stem-progenitor cells inhibit human immunodeficiency virus replication
    Bonyhadi, ML
    Moss, K
    Voytovich, A
    Auten, J
    Kalfoglou, C
    Plavec, I
    Forestell, S
    Su, LS
    Bohnlein, E
    Kaneshima, H
    [J]. JOURNAL OF VIROLOGY, 1997, 71 (06) : 4707 - 4716
  • [7] CELLS INDUCED TO EXPRESS A HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENVELOPE GENE MUTANT INHIBIT THE SPREAD OF WILD-TYPE VIRUS
    BUCHSCHACHER, GL
    FREED, EO
    PANGANIBAN, AT
    [J]. HUMAN GENE THERAPY, 1992, 3 (04) : 391 - 397
  • [8] MOLECULAR TARGETS OF GENE-TRANSFER THERAPY FOR HIV-INFECTION
    BUCHSCHACHER, GL
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 269 (22): : 2880 - 2886
  • [9] Buchschacher GL, 2000, BLOOD, V95, P2499
  • [10] Caputo A, 1996, GENE THER, V3, P235